Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Not currently on drug therapy for type 2 diabetes~* Blood glucose criteria must be met~* Body mass index (BMI) in the range 22-45~Exclusion Criteria:~* History of type 1 diabetes~* Evidence of significant diabetic complications~* Serious cardiovascular events within the past 6 months~* Laboratory value abnormalities as defined by the protocol~* Other protocol-defined exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).